- Home
- SFST vs RCKT Comparison
SFST vs RCKT Comparison
Compare SFST & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- RCKT
- Stock Information
- Founded
- SFST 1999
- RCKT 1999
- Country
- SFST United States
- RCKT United States
- Employees
- SFST N/A
- RCKT N/A
- Industry
- SFST Major Banks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- SFST Finance
- RCKT Health Care
- Exchange
- SFST Nasdaq
- RCKT Nasdaq
- Market Cap
- SFST 335.4M
- RCKT 328.6M
- IPO Year
- SFST 1999
- RCKT N/A
- Fundamental
- Price
- SFST $44.48
- RCKT $3.22
- Analyst Decision
- SFST Buy
- RCKT Buy
- Analyst Count
- SFST 1
- RCKT 13
- Target Price
- SFST $51.00
- RCKT $12.96
- AVG Volume (30 Days)
- SFST 18.7K
- RCKT 5.7M
- Earning Date
- SFST 10-21-2025
- RCKT 11-06-2025
- Dividend Yield
- SFST N/A
- RCKT N/A
- EPS Growth
- SFST 58.48
- RCKT N/A
- EPS
- SFST 2.69
- RCKT N/A
- Revenue
- SFST $102,878,000.00
- RCKT N/A
- Revenue This Year
- SFST $8.65
- RCKT N/A
- Revenue Next Year
- SFST $13.43
- RCKT $108.43
- P/E Ratio
- SFST $16.62
- RCKT N/A
- Revenue Growth
- SFST 15.60
- RCKT N/A
- 52 Week Low
- SFST $29.14
- RCKT $2.19
- 52 Week High
- SFST $46.00
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- SFST 54.89
- RCKT 49.27
- Support Level
- SFST $44.13
- RCKT $3.12
- Resistance Level
- SFST $45.36
- RCKT $3.30
- Average True Range (ATR)
- SFST 0.88
- RCKT 0.18
- MACD
- SFST -0.14
- RCKT -0.02
- Stochastic Oscillator
- SFST 30.59
- RCKT 20.03
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.